A safety update on sodium glucose co‐transporter 2 inhibitors
D Fitchett - Diabetes, Obesity and Metabolism, 2019 - Wiley Online Library
Sodium glucose co‐transporter 2 inhibitors (SGLT2is) are the first class of glucose lowering
agent to be shown to reduce cardiovascular events. They are generally well tolerated with …
agent to be shown to reduce cardiovascular events. They are generally well tolerated with …
A safety update on sodium glucose co-transporter 2 inhibitors
D Fitchett - Diabetes, obesity & metabolism, 2019 - pubmed.ncbi.nlm.nih.gov
Sodium glucose co-transporter 2 inhibitors (SGLT2is) are the first class of glucose lowering
agent to be shown to reduce cardiovascular events. They are generally well tolerated with …
agent to be shown to reduce cardiovascular events. They are generally well tolerated with …
A safety update on sodium glucose co-transporter 2 inhibitors.
D Fitchett - Diabetes, Obesity & Metabolism, 2019 - europepmc.org
Sodium glucose co-transporter 2 inhibitors (SGLT2is) are the first class of glucose lowering
agent to be shown to reduce cardiovascular events. They are generally well tolerated with …
agent to be shown to reduce cardiovascular events. They are generally well tolerated with …
A safety update on sodium glucose co‐transporter 2 inhibitors.
D Fitchett - Diabetes, Obesity & Metabolism, 2019 - search.ebscohost.com
Sodium glucose co‐transporter 2 inhibitors (SGLT2is) are the first class of glucose lowering
agent to be shown to reduce cardiovascular events. They are generally well tolerated with …
agent to be shown to reduce cardiovascular events. They are generally well tolerated with …